Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Wnt and Notch pathways are crucial for repairing blood stem cells after damage.

Lrig1 could be a marker for advanced sebaceous carcinoma.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Desmoglein 3 is important for keeping hair follicle stem cells inactive and maintaining their special properties.

CTCF protein is essential for skin and hair follicle development in mice.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Integrin α6 helps identify different neural crest cell types in the skin.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

The Notch signaling pathway helps in mouse hair development through a noncanonical mechanism that does not rely on RBPj or transcription.

A3 antibody helps identify key cells in rat hair follicle development.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Notch1 helps skin heal by attracting specific immune cells.

Tcf3 and Lef1 are key in deciding skin stem cell roles.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Lower SMAD2/3 activation predicts more severe skin cancer.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

The BMP/Smads pathway and Id2 gene control hair follicle stem cells, affecting their rest and growth phases.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.